Wednesday, May 21, 2025

Radformation to Accelerate AI-Based Solutions with Limbus AI Acquisition

Related stories

Accenture, Dell & NVIDIA Accelerate Enterprise AI with AI Refinery

New AI solution helps organizations scale AI in private,...

Virtana Launches First Full-Stack AI Factory Monitoring

Unique new capabilities help enterprises tame AI infrastructure complexity,...

15Five Debuts Kona AI Manager Coach at 15Five Next

Kona provides tailored coaching and enablement to managers in...

Dell Revamps Data Centers with Software-Driven Infrastructure

Dell software-driven advancements automate the management and deployment of...

Deloitte to Integrate Zora AI™ With SAP Joule for Reasoning

The planned integration will allow Zora AI and SAP...
spot_imgspot_img

Radformation, Inc., a leader in automation solutions for cancer care, announced that it has acquired privately-held Limbus AI, a leading global provider of automated contouring software for radiation therapy. This acquisition signifies Radformation’s commitment to driving innovation and expanding its AI-driven capabilities in cancer care.

“Our mission has always been to improve the radiation therapy process, focusing on efficiency, quality, and safety in patient care,” said Kurt Sysock, CEO of Radformation. “With Limbus’ innovative technology and expertise now part of our team, we are even more equipped to advance the frontier of innovative software solutions in radiation therapy.”

This merger aims to harness the collective strengths of both companies’ platforms by integrating the superior features of each system, offering the most advanced AI-driven contouring solution available today. Beyond improving contouring, this effort is expected to spark further innovation, leading to new developments and improvements in radiation therapy.

Also Read: Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.

“We share a similar vision to bring innovative software to patient care,” said Karl Otto, CEO of Limbus AI. “Both companies have very talented and hard working teams that, when combined, will be able to achieve great things together.”

Radformation’s acquisition of Limbus AI unites two leaders in clinical treatment planning, combining Radformation’s extensive global presence and robust product utilization – spanning 8 products used in over 1,600 clinics in 28 countries – with Limbus’ significant impact on 500,000 patients across 400 centers worldwide. This alliance will accelerate innovation, expand reach, and enhance patient outcomes worldwide, marking a new era in healthcare technology.

Source: BusinessWire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img